Editorial: Early Treatment With Dornase Alfa in Cystic Fibrosis: What Are the Issues?

Aerosolized dornase alfa in cystic fibro

Aerosolized dornase alfa in cystic fibrosis: Is there a role in the management of patients with early obstructive lung disease?

✍ David E. Geller 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 3 views

Airway inflammation and infection are present in patients with mild lung disease in cystic fibrosis (CF), suggesting the need for early treatment. In a previously reported large multicenter trial, dornase alfa improved pulmonary function and decreased the need for hospitalization in patients with CF